查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
總體基因體學市場 - 全球和區域分析：按類型、按工作流程、按技術、按應用、按地區 - 分析和預測（2024-2033）
市場調查報告書
商品編碼
1513715

總體基因體學市場 - 全球和區域分析：按類型、按工作流程、按技術、按應用、按地區 - 分析和預測（2024-2033）

Metagenomics Market - A Global and Regional Analysis: Focus on Type, Workflow, Technology, Application, and Region - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 133 Pages | 商品交期: 1-5個工作天內

價格

2023年全球總體基因體學市場規模將達18.08億美元。

預計2024年至2033年該市場將以17.90%的複合年成長率成長，2033年達到92.861億美元。透過探索實驗室無法培養的大量微生物群落，總體基因體學市場正在經歷顯著成長。總體基因體學是使用基因組分析工具直接從環境樣本中研究微生物基因組的領域，徹底改變了我們對微生物多樣性和功能的理解。該市場的推動因素包括定序技術的進步、人們對微生物對健康影響的認知不斷提高，以及總體基因體學在農業、生物技術和環境修復等各個領域的應用。對個人化醫療的快速成長的需求以及對新型抗生素和酶的需求正在推動市場進一步發展，使總體基因體學成為科學研究和商業應用的寶貴資源。

主要市場統計數據
預測期 2024-2033
2024年評估 21.1億美元
2033年預測 92.861 億美元
複合年成長率 17.9%

由於基因序列測定技術進步的融合以及人們對微生物世界對健康和環境影響的認知不斷增強，全球總體基因體學市場正在迅速擴大。該市場利用總體基因體學的力量來破解直接從環境樣本中提取的微生物群落的遺傳物質，繞過傳統的培養方法。主要促進因素包括對改進診斷技術的需求不斷增加、生物修復中微生物功能的探索以及農業部門促進永續實踐。全球總體基因體學市場準備應對醫療保健、永續性和生物創新的緊迫挑戰，其應用範圍涵蓋醫學研究、環境科學和農業。市場按產品類型、工作流程、應用、技術和地區進行細分。

該報告研究了全球總體基因體學市場，並提供了市場概述，包括按類型、工作流程、技術、應用、區域和參與市場的公司概況分類的趨勢。

目錄

執行摘要

第1章 市場

  • 生態系概述：總體基因體學市場
  • 趨勢：當前和未來的影響評估
  • 研究發展回顧
  • 監管狀況
  • 市場動態

第2章全球總體基因體學市場，依類型

  • 產品

第3章全球總體基因體學市場，依工作流程

  • 樣品製備（測序前）
  • 定序
  • 資料分析

第4章依科技分類的全球總體基因體學市場

  • 毛細管電泳
  • 單分子定序
  • 合成定定序
  • 連接定序列測定
  • 奈米孔定序
  • 其他

第5章全球總體基因體學市場，依應用分類

  • 臨床診斷
  • 產業
  • 研究

第6章 區域

  • 區域概況
  • 促進因素和抑制因素
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章市場－競爭基準化分析和公司概況

  • 未來展望
  • 生態系中的關鍵參與者
  • 企業市場占有率分析
  • 主要策略及發展
    • BGI Genomics
    • Eurofins Scientific
    • Illumina, Inc.
    • MGI Tech Co., Ltd.
    • Oxford Nanopore Technologies plc
    • Pacific Biosciences of California, Inc.
    • Macrogen, Inc.
    • Qiagen NV
    • Revvity, Inc. (PerkinElmer, Inc.)
    • Thermo Fisher Scientific, Inc.
    • 總體基因體學市場的新興企業

第8章調查方法

Product Code: BHP2182SA

Global Metagenomics Market Industry Overview

The global metagenomics market was valued at $1,808.0 million in 2023 and is expected to reach $9,286.1 million by 2033, growing at a CAGR of 17.90% between 2024 and 2033. The metagenomics market has experienced significant growth as it explores the vast array of microbial communities that cannot be cultured in the lab. Metagenomics, a field that employs genomic analysis tools to study microbial genomes directly from environmental samples, has revolutionized our understanding of microbial diversity and functionality. This market is driven by advancements in sequencing technologies, increasing awareness of microbial influence on health, and the application of metagenomics in various sectors such as agriculture, biotechnology, and environmental restoration. The surge in demand for personalized medicine and the need for novel antibiotics and enzymes are further propelling the market forward, making metagenomics an invaluable resource in both scientific research and commercial applications.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$2,110.0 Million
2033 Forecast$9,286.1 Million
CAGR17.9%

The global metagenomics market is rapidly expanding, fueled by the convergence of technological advancements in genetic sequencing and a growing recognition of the microbial world's impact on health and the environment. This market leverages the power of metagenomics to decode genetic material from microbial communities directly extracted from environmental samples, bypassing traditional culturing methods. Key drivers include the rising demand for improved diagnostic techniques, the exploration of microbial functions in bioremediation, and the agricultural sector's push for sustainable practices. With its applications spanning from medical research to environmental science and agriculture, the global metagenomics market is poised to address some of the most pressing challenges in healthcare, sustainability, and bio innovation. The market includes segments such as by product type, by workflow, by application, by technology, and by region.

Industrial Impact

The industrial impact of the global metagenomics market is profound and multifaceted, influencing a variety of sectors. In healthcare, metagenomics is revolutionizing the development of novel diagnostics and therapeutics, particularly in understanding the human microbiome's role in disease and health. This has led to the creation of more targeted treatments and the identification of new drug candidates. In the environmental sector, metagenomics assists in monitoring biodiversity and the health of ecosystems, crucial for environmental conservation and remediation efforts. Additionally, in agriculture, it enhances soil health analysis and crop yield predictions, contributing to sustainable farming practices. The biotechnology field also benefits significantly, as metagenomics facilitates enzyme discovery and the development of new biochemical processes, which are essential for industrial bioprocessing and bioenergy production. Overall, the expansion of metagenomics is driving innovation across these industries, leading to more sustainable practices and improved health outcomes.

Market Segmentation:

Segmentation 1: by Product Type

  • Consumables
  • Instruments
  • Services and Software

Consumables Segment to Dominate the Metagenomics Market (by Product Type)

The consumables segment is poised to dominate the metagenomics market by product type, reflecting its critical role in the array of metagenomic workflows and processes. Consumables, including reagents, kits, and other disposable components, are essential for extracting, sequencing, and analysing genetic material from environmental samples. Their high usage rate and the need for regular replenishment drive their demand, making them a continual source of revenue for companies in the field. The segment's growth is bolstered by the increasing number of metagenomic studies aimed at understanding microbial diversity and function across various applications in healthcare, agriculture, and environmental science. As next generation sequencing technologies advance and become more accessible, the demand for these consumables is expected to surge, further cementing their leading position in the market.

Segmentation 2: by Workflow

  • Sample Preparation (Pre-Sequencing)
  • Sequencing
  • Data Analysis

Sample Preparation (Pre-Sequencing) Segment to Dominate the Metagenomics Market (by Workflow)

The sample preparation (pre-sequencing) segment is expected to dominate the metagenomics market by workflow, underscoring its pivotal role in the success of metagenomic analyses. This segment involves critical steps such as the extraction of DNA from diverse and often challenging environmental samples, which is fundamental to the integrity of the subsequent sequencing and analysis. The precision and quality of sample preparation directly influence the accuracy and reliability of metagenomics data, making it a crucial area of investment for researchers and companies alike. With the expanding scope of metagenomics applications in complex environments like oceanic and soil microbiomes, the demand for robust and efficient pre-sequencing technologies is increasing. This trend is driving innovations and improvements in sample preparation kits and protocols, ensuring that this segment maintains its dominant position in the workflow of the metagenomics market.

Segmentation 3: by Technology

  • Capillary Electrophoresis
  • Single Molecule Sequencing
  • Sequencing by Synthesis
  • Sequencing by Ligation
  • Nanopore Sequencing
  • Other Technologies

Sequencing by Synthesis Segment to Dominate the Metagenomics Market (by Formulation)

The sequencing by synthesis segment is poised to lead the metagenomics market by formulation, indicating its prominence in the field. This segment involves the use of sequencing technologies that rely on the synthesis of complementary DNA strands during the sequencing process. Its dominance underscores its effectiveness in generating high-quality sequencing data from metagenomic samples. As the demand for accurate and efficient sequencing methods continues to rise, particularly in the exploration of microbial communities across diverse environments, the sequencing by synthesis segment is expected to maintain its predominant position within the metagenomics market.

Segmentation 4: by Application

  • Clinical Diagnostics
  • Industrial Applications
  • Research Applications

Research Application Segment to Dominate the Metagenomics Market (by Application)

The research application segment is anticipated to lead the metagenomics market by application, highlighting its significance in advancing scientific understanding across various fields. This segment encompasses a wide range of research, including studies aimed at elucidating the diversity, function, and interactions of microbial communities in different environments. Metagenomics plays a pivotal role in addressing critical research questions in areas such as human health, environmental conservation, agriculture, and biotechnology. As the demand for comprehensive insights into microbial ecosystems continues to grow, driven by the need for innovative solutions to global challenges, the Research Application segment is expected to maintain its dominance in driving advancements and discoveries in the metagenomics market.

Segmentation 5: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • India
    • China
    • South Korea
    • Australia
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa
    • South Africa
    • U.A.E.
    • Rest-of-Middle East and Africa

The North America segment is positioned to hold a significant share in the global metagenomics market for several compelling reasons. The North America segment is poised to command a substantial share of the global metagenomics market due to various compelling factors. With a robust infrastructure for research and development, coupled with significant investments in biotechnology and life sciences, North America stands at the forefront of metagenomics innovation. Moreover, the region boasts a concentration of leading biotechnology and pharmaceutical companies, fostering collaborations and partnerships that drive advancements in metagenomic technologies and applications. Additionally, the growing awareness of the role of microbial communities in human health and the environment has spurred increased research funding and initiatives in North America, further propelling the growth of the metagenomics market in the region.

Recent Developments in the Metagenomics Market

  • In January 2024, Eurofins Genomics announced the establishment of a newly certified sequencing laboratory in Bothell, Washington, catering to the larger Seattle region. Utilizing the Oxford Nanopore sequencing platform and its nearby location, the facility ensures results are delivered within 12 hours of sample collection. The company has established partnerships with 30 laboratories in Seattle and conducts daily sample collection and sequencing for the biotech hub.
  • In February 2024, MGI Tech Co., Ltd. Tech Co., Ltd. revealed a collaboration agreement with MetaGenoPolis, a division of the esteemed National Research Institute for Agriculture, Food and the Environment in France. This collaboration comes after MetaGenoPolis was chosen as a core lab for the Million Microbiomes from Humans Project.
  • In June 2023, Eurofins Genomics U.S. introduces the express oxford nanopore sequencing service, providing same-day results.
  • In March 2023, Macrogen Inc. announced the launch of NovaSeq X Plus to Korea, marking the system's debut in the Asian market.

Demand - Drivers, Challenges, and Opportunities

Market Demand Drivers:

Significant Reduction in Sequencing Costs Leading to an Increase In the Number of Metagenomics Studies: One of the most notable drivers in the global metagenomics market is the substantial reduction in the costs associated with sequencing This decrease in pricing has made sequencing more accessible across various sectors including healthcare, research, and personalized medicine. Consequently, there has been a reported rise in the volume of metagenomics research and its application in clinical settings for the analysis of genetic sequences.

Market Challenges:

Challenge of Securely Storing Vast Volumes of Sequenced Data: A key restraint in the global metagenomics market is the challenge of securely storing the vast volumes of sequenced data. With significant growth driven by technological advances, reduced sequencing costs, and governmental support for genomic applications in personalized medicine, there's been a surge in genomic testing and, consequently, data generation.

Market Opportunities:

Opportunity for Metagenomics in Microplastic Remediation: Metagenomics plays a crucial role in uncovering new microbial communities for tackling the issue of microplastic pollution. Microplastics, tiny plastic fragments posing significant environmental challenges, are increasingly found across diverse ecosystems due to human activities. Their enduring nature and the risk they pose to living organisms through biomagnification necessitate the development of effective remediation techniques.

How can this Report add value to an Organization?

Product/Innovation Strategy: The global metagenomics market has been segmented based on various categories, such as product type, workflow, technology, application, and region.

Growth/Marketing Strategy: Partnerships, alliances, and business expansions together accounted for the maximum number of key developments of the total developments in the global metagenomics market between January 2021 and April 2024.

Competitive Strategy: Key players are investing heavily in research and development to enhance their product portfolios and develop cutting-edge technologies for sample preparation, sequencing, and analysis. Strategic collaborations with academic institutions, research organizations, and industry partners are also key, facilitating access to diverse datasets and expertise. Furthermore, companies are focusing on expanding their market presence through geographic expansion and strategic acquisitions to capitalize on emerging opportunities and consolidate their market position.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2019-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2033.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of metagenomics instruments, consumables, and services.
  • The market contribution of metagenomics is anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
  • Revenues of the companies have been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available PMS and menstrual health supplement solutions. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in metagenomics, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of the report's segmentation and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of the different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research:

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others.
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players of the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

The research applications is leading the market and captured around 55.07% of the market's presence as of 2023. Clinical Diagnostics, on the other hand, accounted for approximately 27.52% of the market presence in 2023.

Some prominent names established in this market are:

  • BGI Genomics
  • Eurofins Scientific
  • Illumina, Inc.
  • MGI Tech Co., Ltd.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • Macrogen, Inc.
  • QIAGEN N.V.
  • Revvity, Inc. (PerkinElmer Inc.)
  • Thermo Fisher Scientific, Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Ecosystem Overview: Metagenomics Market
  • 1.2 Trends: Current and Future Impact Assessment
    • 1.2.1 Expansion into New Application Areas
    • 1.2.2 Increasing Collaborations and Partnerships among Key Players
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Company)
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics
    • 1.5.1 Market Drivers
      • 1.5.1.1 Significant Reduction in Sequencing Costs Leading to an Increase in the Number of Metagenomics Studies
      • 1.5.1.2 High Incidence of Infectious Diseases
      • 1.5.1.3 Technological Advancements in Metagenomics
    • 1.5.2 Market Restraints
      • 1.5.2.1 Challenge of Securely Storing Vast Volumes of Sequenced Data
      • 1.5.2.2 Challenges Involved in Data Analysis of Metagenomics Sequencing and Lack of Clear Knowledge
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Opportunity for Metagenomics in Microplastic Remediation
      • 1.5.3.2 Focus on Metagenomics Research on Antibiotic-Resistant Bacteria and Antibiotic-Resistant Genes

2 Global Metagenomics Market, by Type

  • 2.1 Product
    • 2.1.1 Consumables
      • 2.1.1.1 Library Preparation Kits
      • 2.1.1.2 Sample Extraction Kits
      • 2.1.1.3 Sequencing Kits
    • 2.1.2 Instruments
    • 2.1.3 Services and Software

3 Global Metagenomics Market, by Workflow

  • 3.1 Sample Preparation (Pre-Sequencing)
  • 3.2 Sequencing
  • 3.3 Data Analysis

4 Global Metagenomics Market, by Technology

  • 4.1 Capillary Electrophoresis
  • 4.2 Single-Molecule Sequencing
  • 4.3 Sequencing by Synthesis
  • 4.4 Sequencing by Ligation
  • 4.5 Nanopore Sequencing
  • 4.6 Other Technologies

5 Global Metagenomics Market, by Application

  • 5.1 Clinical Diagnostics
    • 5.1.1 Blood Stream Infection
    • 5.1.2 Central Nervous System Infection
    • 5.1.3 Respiratory Infection
    • 5.1.4 Others
  • 5.2 Industrial Applications
    • 5.2.1 Agriculture
  • 5.3 Research Applications
    • 5.3.1 Antibiotic Resistance
    • 5.3.2 Gut Microbe Characterization
    • 5.3.3 Environmental Remediation
    • 5.3.4 Other Research Applications

6 Regions

  • 6.1 Regional Summary
  • 6.2 Drivers and Restraints
  • 6.3 North America
    • 6.3.1 Regional Overview
    • 6.3.2 Factors Driving the Market Growth
    • 6.3.3 Factors Impeding/Limiting the Market Growth
    • 6.3.4 By Type
    • 6.3.5 By Application
    • 6.3.6 U.S.
      • 6.3.6.1 By Type
      • 6.3.6.2 By Application
    • 6.3.7 Canada
      • 6.3.7.1 By Type
      • 6.3.7.2 By Application
  • 6.4 Europe
    • 6.4.1 Regional Overview
    • 6.4.2 Factors Driving the Market Growth
    • 6.4.3 Factors Impeding/Limiting the Market Growth
    • 6.4.4 By Type
    • 6.4.5 By Application
    • 6.4.6 Germany
      • 6.4.6.1 By Type
      • 6.4.6.2 By Application
    • 6.4.7 U.K.
      • 6.4.7.1 By Type
      • 6.4.7.2 By Application
    • 6.4.8 France
      • 6.4.8.1 By Type
      • 6.4.8.2 By Application
    • 6.4.9 Italy
      • 6.4.9.1 By Type
      • 6.4.9.2 By Application
    • 6.4.10 Spain
      • 6.4.10.1 By Type
      • 6.4.10.2 By Application
    • 6.4.11 Rest-of-Europe
      • 6.4.11.1 By Type
      • 6.4.11.2 By Application
  • 6.5 Asia-Pacific
    • 6.5.1 Regional Overview
    • 6.5.2 Factors Driving the Market Growth
    • 6.5.3 Factors Impeding/Limiting the Market Growth
    • 6.5.4 By Type
    • 6.5.5 By Application
    • 6.5.6 China
      • 6.5.6.1 By Type
      • 6.5.6.2 By Application
    • 6.5.7 Japan
      • 6.5.7.1 By Type
      • 6.5.7.2 By Application
    • 6.5.8 India
      • 6.5.8.1 By Type
      • 6.5.8.2 By Application
    • 6.5.9 Australia
      • 6.5.9.1 By Type
      • 6.5.9.2 By Application
    • 6.5.10 South Korea
      • 6.5.10.1 By Type
      • 6.5.10.2 By Application
    • 6.5.11 Rest-of-Asia-Pacific
      • 6.5.11.1 By Type
      • 6.5.11.2 By Application
  • 6.6 Latin America
    • 6.6.1 Regional Overview
    • 6.6.2 Factors Driving the Market Growth
    • 6.6.3 Factors Impeding/Limiting the Market Growth
    • 6.6.4 By Type
    • 6.6.5 By Application
    • 6.6.6 Brazil
      • 6.6.6.1 By Type
      • 6.6.6.2 By Application
    • 6.6.7 Mexico
      • 6.6.7.1 By Type
      • 6.6.7.2 By Application
    • 6.6.8 Rest-of-Latin America
      • 6.6.8.1 By Type
      • 6.6.8.2 By Application
  • 6.7 Middle East and Africa
    • 6.7.1 Regional Overview
    • 6.7.2 Factors Driving the Market Growth
    • 6.7.3 Factors Impeding/Limiting the Market Growth
    • 6.7.4 By Type
    • 6.7.5 By Application
    • 6.7.6 U.A.E.
      • 6.7.6.1 By Type
      • 6.7.6.2 By Application
    • 6.7.7 South Africa
      • 6.7.7.1 By Type
      • 6.7.7.2 By Application
    • 6.7.8 Rest-of-Middle East and Africa
      • 6.7.8.1 By Type
      • 6.7.8.2 By Application

7 Markets - Competitive Benchmarking & Company Profiles

  • 7.1 Next Frontiers
  • 7.2 Active Key Players in The Ecosystem
  • 7.3 Company Share Analysis
  • 7.4 Key Strategies and Developments
    • 7.4.1 BGI Genomics
      • 7.4.1.1 Overview
      • 7.4.1.2 Top Products
      • 7.4.1.3 Top Competitors
      • 7.4.1.4 Key Personnel
      • 7.4.1.5 Analyst View
    • 7.4.2 Eurofins Scientific
      • 7.4.2.1 Overview
      • 7.4.2.2 Top Products
      • 7.4.2.3 Top Competitors
      • 7.4.2.4 Key Personnel
      • 7.4.2.5 Analyst View
    • 7.4.3 Illumina, Inc.
      • 7.4.3.1 Overview
      • 7.4.3.2 Top Products/Product Portfolio
      • 7.4.3.3 Top Competitors
      • 7.4.3.4 Key Personnel
      • 7.4.3.5 Analyst View
    • 7.4.4 MGI Tech Co., Ltd.
      • 7.4.4.1 Overview
      • 7.4.4.2 Top Products/Product Portfolio
      • 7.4.4.3 Top Competitors
      • 7.4.4.4 Key Personnel
      • 7.4.4.5 Analyst View
    • 7.4.5 Oxford Nanopore Technologies plc
      • 7.4.5.1 Overview
      • 7.4.5.2 Top Products
      • 7.4.5.3 Top Competitors
      • 7.4.5.4 Key Personnel
      • 7.4.5.5 Analyst View
    • 7.4.6 Pacific Biosciences of California, Inc.
      • 7.4.6.1 Overview
      • 7.4.6.2 Top Products/Product Portfolio
      • 7.4.6.3 Top Competitors
      • 7.4.6.4 Key Personnel
      • 7.4.6.5 Analyst View
    • 7.4.7 Macrogen, Inc.
      • 7.4.7.1 Overview
      • 7.4.7.2 Top Products/Product Portfolio
      • 7.4.7.3 Top Competitors
      • 7.4.7.4 Key Personnel
      • 7.4.7.5 Analyst View
    • 7.4.8 Qiagen N.V.
      • 7.4.8.1 Overview
      • 7.4.8.2 Top Products/Product Portfolio
      • 7.4.8.3 Top Competitors
      • 7.4.8.4 Key Personnel
      • 7.4.8.5 Analyst View
    • 7.4.9 Revvity, Inc. (PerkinElmer, Inc.)
      • 7.4.9.1 Overview
      • 7.4.9.2 Top Products/Product Portfolio
      • 7.4.9.3 Top Competitors
      • 7.4.9.4 Key Personnel
      • 7.4.9.5 Analyst View
    • 7.4.10 Thermo Fisher Scientific, Inc.
      • 7.4.10.1 Overview
      • 7.4.10.2 Top Products/Product Portfolio
      • 7.4.10.3 Top Competitors
      • 7.4.10.4 Key Personnel
      • 7.4.10.5 Analyst View
    • 7.4.11 Emerging Companies in the Metagenomics Market

8 Research Methodology

  • 8.1 Data Sources
    • 8.1.1 Primary Data Sources
    • 8.1.2 Secondary Data Sources
    • 8.1.3 Data Triangulation
  • 8.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Metagenomics Market, $Million, 2024, 2028 and 2033
  • Figure 2: Global Metagenomics Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Global Metagenomics Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 4: Global Metagenomics Market (by Clinical Diagnostics), $Million, 2023, 2027, and 2033
  • Figure 5: Global Metagenomics Market (by Workflow), $Million, 2023, 2027, and 2033
  • Figure 6: Global Metagenomics Market (by Product Type), $Million, 2023, 2027, and 2033
  • Figure 7: Global Metagenomics Market (by Technology), $Million, 2023, 2027, and 2033
  • Figure 8: Key Industrial Developments in Global Metagenomics Market, 2023-2024
  • Figure 9: Ecosystem Overview and Operational Challenges
  • Figure 10: Applications of Metagenomics in Different Research Areas
  • Figure 11: Strategies Undertaken by Key Players, 2021-2024
  • Figure 12: Strategic Collaborations and Partnerships, January 2021-April 2024
  • Figure 13: Number of Metagenomics Patents (by Country), January 2020-April 2024
  • Figure 14: Number of Metagenomics Patents (by Year), January 2020-December 2023
  • Figure 15: Impact Analysis of Market Navigating Factors, 2023-2033
  • Figure 16: Sequencing Cost over Time, 2007, 2014 and 2023
  • Figure 17: Increase in Number of Metagenomics Publications, 2019-2023
  • Figure 18: Estimated Number of Incident Tuberculosis Cases, Globally, Million, 2016 and 2021
  • Figure 19: Incidence of Influenza A and B in India, Million, 2022-2033
  • Figure 20: Increase in Metagenomics Research and Infectious Disease Publications, 2019-2023
  • Figure 21: Advancements in the Metagenomics Market (by Technology)
  • Figure 22: Challenges Related to Storing Sequenced Data
  • Figure 23: Global Plastic Pollution, 1950-2050
  • Figure 24: Forecasted Death Rates from Antimicrobial Resistance Vs. Current Leading Causes of Mortality
  • Figure 25: Workflow of Metagenomics Market
  • Figure 26: U.S. Metagenomics Market, $Million, 2023-2033
  • Figure 27: Canada Metagenomics Market, $Million, 2023-2033
  • Figure 28: Germany Metagenomics Market, $Million, 2023-2033
  • Figure 29: U.K. Metagenomics Market, $Million, 2023-2033
  • Figure 30: France Metagenomics Market, $Million, 2023-2033
  • Figure 31: Italy Metagenomics Market, $Million, 2023-2033
  • Figure 32: Spain Metagenomics Market, $Million, 2023-2033
  • Figure 33: Rest-of-Europe Metagenomics Market, $Million, 2023-2033
  • Figure 34: China Metagenomics Market, $Million, 2023-2033
  • Figure 35: Japan Metagenomics Market, $Million, 2023-2033
  • Figure 36: India Metagenomics Market, $Million, 2023-2033
  • Figure 37: Australia Metagenomics Market, $Million, 2023-2033
  • Figure 38: South Korea Metagenomics Market, $Million, 2023-2033
  • Figure 39: Rest-of-Asia-Pacific Metagenomics Market, $Million, 2023-2033
  • Figure 40: Brazil Metagenomics Market, $Million, 2023-2033
  • Figure 41: Mexico Metagenomics Market, $Million, 2023-2033
  • Figure 42: Rest-of-Latin America Metagenomics Market, $Million, 2023-2033
  • Figure 43: U.A.E. Metagenomics Market, $Million, 2023-2033
  • Figure 44: South Africa Metagenomics Market, $Million, 2023-2033
  • Figure 45: Rest-of-Middle East and Africa Metagenomics Market, $Million, 2023-2033
  • Figure 46: Strategic Initiatives, 2021-2024
  • Figure 47: Share of Strategic Initiatives, 2021-2024
  • Figure 48: Strategic Initiatives (by Year), 2021-2024
  • Figure 49: Data Triangulation
  • Figure 50: Top-Down and Bottom-Up Approach
  • Figure 51: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Metagenomics Market, Market Opportunities
  • Table 3: Key Players and their Competence
  • Table 4: Key Trends, Global Metagenomics Market
  • Table 5: Examples of Metagenomics in New Applications
  • Table 6: Regulatory Scenario of Metagenomics
  • Table 7: Different Generations of NGS Platforms Showing Technological Advancements
  • Table 8: Global Metagenomics Market, by Type, $Million, 2023-2033
  • Table 9: Global Metagenomics Market, by Consumables, (by Type), $Million, 2023-2033
  • Table 10: Global Metagenomics Market, by Workflow, $Million, 2023-2033
  • Table 11: Global Metagenomics Market, by Technology, $Million, 2023-2033
  • Table 12: Global Metagenomics Market, by Application, $Million, 2023-2033
  • Table 13: Global Metagenomics Market, Clinical Diagnostics, (by Type), $Million, 2023-2033
  • Table 14: Global Metagenomics Market, Research Application, (by Type), $Million, 2023-2033
  • Table 15: Global Metagenomics Market (by Region), $Million, 2023-2033
  • Table 16: North America Metagenomics Market (by Type), $Million, 2023-2033
  • Table 17: North America Metagenomics Market (by Application), $Million, 2023-2033
  • Table 18: U.S. Metagenomics Market (by Type), $Million, 2023-2033
  • Table 19: U.S. Metagenomics Market (by Application), $Million, 2023-2033
  • Table 20: Canada Metagenomics Market (by Type), $Million, 2023-2033
  • Table 21: Canada Metagenomics Market (by Application), $Million, 2023-2033
  • Table 22: Europe Metagenomics Market (by Type), $Million, 2023-2033
  • Table 23: Europe Metagenomics Market (by Application), $Million, 2023-2033
  • Table 24: Germany Metagenomics Market (by Type), $Million, 2023-2033
  • Table 25: Germany Metagenomics Market (by Application), $Million, 2023-2033
  • Table 26: U.K. Metagenomics Market (by Type), $Million, 2023-2033
  • Table 27: U.K. Metagenomics Market (by Application), $Million, 2023-2033
  • Table 28: France Metagenomics Market (by Type), $Million, 2023-2033
  • Table 29: France Metagenomics Market (by Application), $Million, 2023-2033
  • Table 30: Italy Metagenomics Market (by Type), $Million, 2023-2033
  • Table 31: Italy Metagenomics Market (by Application), $Million, 2023-2033
  • Table 32: Spain Metagenomics Market (by Type), $Million, 2023-2033
  • Table 33: Spain Metagenomics Market (by Application), $Million, 2023-2033
  • Table 34: Rest-of-Europe Metagenomics Market (by Type), $Million, 2023-2033
  • Table 35: Rest-of-Europe Metagenomics Market (by Application), $Million, 2023-2033
  • Table 36: Asia-Pacific Metagenomics Market (by Type), $Million, 2023-2033
  • Table 37: Asia-Pacific Metagenomics Market (by Application), $Million, 2023-2033
  • Table 38: China Metagenomics Market (by Type), $Million, 2023-2033
  • Table 39: China Metagenomics Market (by Application), $Million, 2023-2033
  • Table 40: Japan Metagenomics Market (by Type), $Million, 2023-2033
  • Table 41: Japan Metagenomics Market (by Application), $Million, 2023-2033
  • Table 42: India Metagenomics Market (by Type), $Million, 2023-2033
  • Table 43: India Metagenomics Market (by Application), $Million, 2023-2033
  • Table 44: Australia Metagenomics Market (by Type), $Million, 2023-2033
  • Table 45: Australia Metagenomics Market (by Application), $Million, 2023-2033
  • Table 46: South Korea Metagenomics Market (by Type), $Million, 2023-2033
  • Table 47: South Korea Metagenomics Market (by Application), $Million, 2023-2033
  • Table 48: Rest-of-Asia-Pacific Metagenomics Market (by Type), $Million, 2023-2033
  • Table 49: Rest-of-Asia-Pacific Metagenomics Market (by Application), $Million, 2023-2033
  • Table 50: Latin America Metagenomics Market (by Type), $Million, 2023-2033
  • Table 51: Latin America Metagenomics Market (by Application), $Million, 2023-2033
  • Table 52: Brazil Metagenomics Market (by Type), $Million, 2023-2033
  • Table 53: Brazil Metagenomics Market (by Application), $Million, 2023-2033
  • Table 54: Mexico Metagenomics Market (by Type), $Million, 2023-2033
  • Table 55: Mexico Metagenomics Market (by Application), $Million, 2023-2033
  • Table 56: Rest-of-Latin America Metagenomics Market (by Type), $Million, 2023-2033
  • Table 57: Rest-of-Latin America Metagenomics Market (by Application), $Million, 2023-2033
  • Table 58: Middle East and Africa Metagenomics Market (by Type), $Million, 2023-2033
  • Table 59: Middle East and Africa Metagenomics Market (by Application), $Million, 2023-2033
  • Table 60: U.A.E. Metagenomics Market (by Type), $Million, 2023-2033
  • Table 61: U.A.E. Metagenomics Market (by Application), $Million, 2023-2033
  • Table 62: South Africa Metagenomics Market (by Type), $Million, 2023-2033
  • Table 63: South Africa Metagenomics Market (by Application), $Million, 2023-2033
  • Table 64: Rest-of-Middle East and Africa Metagenomics Market (by Type), $Million, 2023-2033
  • Table 65: Rest-of-Middle East and Africa Metagenomics Market (by Application), $Million, 2023-2033
  • Table 66: Some of the Key Players in Global Metagenomics Market
  • Table 67: Company Market Share, 2023
  • Table 68: Emerging Companies in Metagenomics Market